Massachusetts General Hospital, Division of Rheumatology — Boston, Massachusetts

Massachusetts General Hospital, Division of Rheumatology is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital, Division of Rheumatology has participated in 1 clinical trials.

Therapeutic areas: Diffuse Cutaneous Systemic Sclerosis.

Sponsors: Corbus Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital, Division of Rheumatology?

Massachusetts General Hospital, Division of Rheumatology has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital, Division of Rheumatology conducted?

Massachusetts General Hospital, Division of Rheumatology has 1 clinical trials on record. Their work covers Diffuse Cutaneous Systemic Sclerosis.

Is Massachusetts General Hospital, Division of Rheumatology accredited by Crixeo Health?

Massachusetts General Hospital, Division of Rheumatology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital, Division of Rheumatology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.